Kleanthis Xanthopoulos

Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA.

Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA.

J.E.M. Capital, Inc. is a a shell company, which engages in the identification of a privately held operating company which desires to become a publicly held entity by merging with the firm through a reverse merger or acquisition. The company was founded on September 14, 2011 and is headquartered in Hong Kong.

Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA.

Bioniz Therapeutics, Inc. operates as a biopharmaceutical firm. The firm engages in the development of peptide therapeutics that selectively and simultaneously inhibit multiple cytokines for the treatment of immune diseases and cancer. The company was founded by Yutaka Tagaya and Nazli Azimi in 2009 and is headquartered in Irvine, CA.

Laboratori Derivati Organici SpA engages in the manufacture and distribution of drugs in pharmaceutical preparations. Its products include Heparinoids, Heparins, and Iron Derivatives. The company was founded in 1960 and is headquartered in Trino, Italy.

Cerus Advisors DMCC (Cerus) is a private equity firm founded in 2015. The firm is headquartered in Dubai with additional offices in UAE and in La Jolla, California, United States.

National Human Genome Research Institute engages in genetic and genomic research. It provides guidance to scientific programs and oversees the general operation. The company was founded in 1989 and is headquartered in Bethesda, MD.

Aspirus, Inc. engages in provision of healthcare services. It offers birthing services, business health, hospice service, inpatient rehabilitation, pain management, stroke care, walk-in care, and wound care. The company is headquartered in Wausau, WI.

Part of Phase Metrics, Inc., Helios, Inc. is a company based in San Diego, CA.

Shoreline Biosciences, Inc. engages in biotechnology business activities. The company is headquartered in La Jolla, CA.

Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China.